<DOC>
	<DOCNO>NCT01055808</DOCNO>
	<brief_summary>This study design address gap literature relate change treatment regimen formulation different type insulin , change impact quality life , adherence , individual patient treatment satisfaction glycemic control .</brief_summary>
	<brief_title>Observational Study Japanese Type 2 Diabetes Patients</brief_title>
	<detailed_description>To measure change Health Related Quality Life ( measure Insulin Therapy Related-Quality Life : ITR-QOL ) insulin treat type 2 diabetes 12 week period follow significant change insulin treatment regimen . Definition significant change ) increase decrease number injection per day , or/and b ) change formulation insulin ( human analog insulin , basal bolus , rapid mix insulin ) , and/or c ) change administration method ( syringe pen , disposal re-usable ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Inpatients outpatient type 2 diabetes , age 20 year old , insulin therapy plan change insulin therapy registration period study Patients provide write informed consent participation study receive explanation objective detail study Patients receive insulin therapy 3 month longer inform consent . ( i.e . receive type insulin preparation dose frequency regardless insulin dose ) Patients plan discontinue insulin therapy Patients incapable complete ITRQOL , DTSQ patient 's questionnaire base selfratings Patients type 1 diabetes Patients use CSII plan switch CSII ( continuous subcutaneous insulin infusion ) Patients poor treatment compliance determine investigator base treatment history</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Insulin</keyword>
	<keyword>ITR-QOL</keyword>
	<keyword>DTSQ</keyword>
	<keyword>Diabetes Mellitus , Type 2</keyword>
</DOC>